Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Delphi Ventures

1.Delphi Ventures   (100%):
Investment Approach How We Work Delphi Ventures is a U.S. venture capital firm focused on early stage healthcare investing, including medical devices and diagnostics, biotechnology, and healthcare services companies. Delphi-backed companies have raised more than $4 billion in capital. More than 50 o...
2.Delphi Ventures   (99%):
Medical Devices and Diagnostics Biotechnology Healthcare Services With over $450 million in committed capital, Delphi's investment interests encompass every segment of the healthcare field, including: Medical Devices and Diagnostics Biotechnology Healthcare Services Copyright © 2002 Delphi Vent...
3.Delphi Ventures   (93%):
All Press Releases 07/07/03 DELPHI VENTURES EXPANDS INVESTMENT TEAM Former EndoTex Interventional Systems, Inc. President & CEO John F. Maroney joins Delphi Ventures as General Partner MENLO PARK, Calif., July 7, 2003 — Delphi Ventures, a venture capital firm focused on early-stage medical devi...
4.Delphi Ventures   (92%):
Partners Extended Team Douglas A. Roeder General Partner Doug joined Delphi Ventures as an Associate in 1998 and became a Partner in 2000. He focuses on medical devices, diagnostics and biotechnology. Before joining Delphi, Doug was an Associate with Alex. Brown's Healthcare Investment Banking Group...
5.Delphi Ventures   (90%):
Partners Extended Team Matt Potter Chief Financial Officer Copyright © 2002 Delphi Ventures, 3000 Sand Hill Road, Building 1, Suite 135, Menlo Park, CA 94025 (650) 854-9650
6.Delphi Ventures   (80%):
Investment Approach How We Work Investment Approach The partners at Delphi Ventures help build healthcare companies. Delphi has been the lead or co-lead investor in more than 75% of its investments. In evaluating investment opportunities, we look for three principal attributes: A proprietary technol...
7.Delphi Ventures   (80%):
Partners Extended Team Our seven partners combine many decades of venture capital expertise with significant senior level operating experience and clinical and laboratory science accomplishments to offer a sensible "can-do" approach to our entrepreneurs and young companies. We work closely with each...
8.Delphi Ventures   (79%):
Partners Extended Team John Maroney General Partner John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments. Prior to joining Delphi, John was President and CEO of EndoTex Interventional Systems, Inc. a development stage, venture backed, star...
9.Delphi Ventures   (78%):
Partners Extended Team David L. Douglass General Partner David joined Delphi Ventures as a General Partner in 1990 and focuses on medical devices and diagnostics. Prior to joining Delphi, David was a General Partner at Matrix Partners, focusing on healthcare investments. From 1984 to 1986, David ser...
10.Delphi Ventures   (76%):
Partners Extended Team Deepa Pakianathan, Ph.D. General Partner Deepa joined Delphi Ventures as a Partner in 2001 and focuses on biotechnology investments. Prior to joining Delphi, Deepa was Vice President and a senior biotechnology banker at JP Morgan. While at JP Morgan, she was involved in health...
11.Delphi Ventures   (72%):
05/09 Adiana, Inc. Reports Completion of Treatment Phase of EASE Transcervical Sterilization Trial >> 04/18 Boston Scientific Announces Acquisition of TriVascular, Inc. >> 04/13 EndoTex Interventional Systems Announces European Approval of Novel Carotid Stent Delivery System >> Cop...
12.Delphi Ventures   (72%):
Partners Extended Team David Douglass Devices Jim Bochnowski Biotechnology and Devices Don Lothrop Healthcare Services Doug Roeder Devices and Biotechnology John Maroney Devices Deepa Pakianathan Biotechnology Kevin Roberg Healthcare Services Copyright © 2002 Delphi Ventures, 3000 Sand Hill Roa...
13.Delphi Ventures   (72%):
05/09 Adiana, Inc. Reports Completion of Treatment Phase of EASE Transcervical Sterilization Trial >> 04/18 Boston Scientific Announces Acquisition of TriVascular, Inc. >> 04/13 EndoTex Interventional Systems Announces European Approval of Novel Carotid Stent Delivery System >> Cop...
14.Easton Capital Investment Group::Salmedix, Inc.   (69%):
Salmedix, Inc. Salmedix is a late stage biopharmaceutical company focusing on in-licensing and development of cancer products. The Company s lead product, SDX-105, is currently in Phase II/III clinical trials for non-Hodgkin s lymphoma. In addition, Salmedix has two drugs in Phase II clinical develo...
15.Delphi Ventures   (68%):
Partners Extended Team James J. Bochnowski General Partner Jim founded Delphi Ventures in 1988. His focus is on biotechnology, medical devices and diagnostics. Jim began investing in medical companies in 1981 after co-founding Technology Venture Investors (TVI), a private venture capital partnership...
16.Delphi Ventures   (68%):
Delphi Ventures 3000 Sand Hill Road Building 1, Suite 135 Menlo Park, CA 94025 (650) 854-9650 Driving Directions From San Jose Airport: Right on Airport Blvd Left on Coleman Avenue Then immediate right to enter Hwy 880 south Take Hwy 280 north for about 15 miles Exit Sand Hill Road east Go straight ...
17.Kaiser Permanente   (65%):
Alloy Ventures www.alloyventures.com Ascension Health Ventures www.ascensionhealthventures.org Bay City Capital www.baycitycapital.com CB Health Ventures www.cbhealthventures.com De Novo Ventures www.denovovc.com Delphi Ventures www.delphiventures.com Domain Ventures www.domainvc.com Draper Fisher V...
18.Delphi Ventures   (65%):
Partners Extended Team Donald J. Lothrop General Partner Don joined Delphi Ventures as a General Partner in 1994 and focuses on healthcare service companies. From 1991 to 1994, Don was a Partner at Marquette Venture Partners in Chicago. His investment focus at Marquette was healthcare services and m...
19.Delphi Ventures   (56%):
Amherst College Champion Ventures Child Health Investments Children's Hospital of Philadelphia Foundation Commonfund Capital Dartmouth College Duke Endowment Duke University Emory University Glenmede Trust Company J.P. Morgan Massachusetts Institute of Technology Mutual Life Insurance Company of Ne...
20.Delphi Ventures   (55%):
Archived Press Releases 12/14/2000 Delphi, Guidant, Frazier Collaborate in Partnership to Rapidly Bring Cardiovascular Technology to Market INDIANAPOLIS—(BW HealthWire)—Dec. 14, 2000—Guidant Corporation, (NYSE:GDT - news; PCX:GDT) a global leader in the development of medical technolo...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others